-+ 0.00%
-+ 0.00%
-+ 0.00%

ULTRAGENYX PHARMACEUTICAL - RECEIVES FDA APPROVAL FOR REBISUFLIGENE ETISPARVOVEC ON SEPT 17, 2026

Reuters·10/02/2026 06:03:32

Please log in to view news